Cancer Family
Mesenchymal Cell Neoplasm
CI-CAN-00000027Explore in graph →
Non-malignant413 active trials10 approved drugs208 evidence items
- NCIt
- C7059
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000027Explore in graph →
Clinical trials
1,848 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00815945 | Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | completed | Phase 2 | 41 | AGO Study GroupOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00585221 | Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients | terminated | Phase 2 | 8 | University of UtahOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00592345 | High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum | completed | Phase 1 / Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00031629 | Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus | completed | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Dec 8, 2016 | clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |
| NCT02571829 | A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | unknown | Phase 2 | 30 | Hadassah Medical OrganizationOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01483014 | Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)(CONVERT) | completed | Phase 2 | 30 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01613313 | A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 14 | Zachary GerutINDIV | 1 | Oct 6, 2016 | clinicaltrials |
| NCT01404650 | Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor | completed | Phase 2 | 25 | SCRI Development Innovations, LLCOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00287846 | Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis | completed | Phase 1 / Phase 2 | 40 | UNICANCEROTHER | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01059656 | Phase II Pazopanib Study in Advanced Dermatofibrosarcomas(DFSP-PAZO) | terminated | Phase 2 | 23 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00003590 | S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | May 20, 2016 | clinicaltrials |
| NCT01478373 | Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib | completed | Phase 2 | 39 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 27, 2016 | clinicaltrials |
| NCT00219778 | A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas | terminated | Phase 2 | 20 | Poitiers University HospitalOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT01039519 | A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) | completed | Phase 2 | 27 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01323400 | Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)(PAZOGIST) | completed | Phase 2 | 81 | Centre Leon BerardOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT00589784 | Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00887809 | Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes | completed | Phase 2 | 47 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00474994 | Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas | completed | Phase 2 | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT00586846 | Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT00608842 | Phase 2 Study for the Treatment of Superficial Lipomas | completed | Phase 2 | 62 | Kythera BiopharmaceuticalsINDUSTRY | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00624416 | Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas | completed | Phase 1 / Phase 2 | 10 | Pennington Biomedical Research CenterOTHER | 1 | Dec 21, 2015 | clinicaltrials |
| NCT00390234 | Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma | completed | Phase 2 | 63 | National Cancer Institute (NCI)NIH | 2 | Dec 7, 2015 | clinicaltrials |
| NCT00837148 | Sorafenib and Dacarbazine in Soft Tissue Sarcoma | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02587169 | Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum(GEIS-27) | unknown | Phase 1 / Phase 2 | 40 | Broto, Javier Martín, M.D.INDIV | 1 | Oct 27, 2015 | clinicaltrials |
| NCT00618319 | An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) | completed | Phase 2 | 20 | BiogenINDUSTRY | 1 | Oct 2, 2015 | clinicaltrials |
| NCT00743509 | A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma(OCR) | completed | Phase 2 | 49 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01016015 | Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma | completed | Phase 2 | 178 | National Cancer Institute (NCI)NIH | 2 | Jul 30, 2015 | clinicaltrials |
| NCT01804374 | Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma(SERIO) | completed | Phase 2 | 38 | Italian Sarcoma GroupNETWORK | 1 | Jun 17, 2015 | clinicaltrials |
| NCT02022358 | Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? | terminated | Phase 2 | 34 | University College, LondonOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT02429973 | Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma(GEIS-29) | completed | Phase 2 | 33 | Broto, Javier Martín, M.D.INDIV | 0 | Apr 29, 2015 | clinicaltrials |
| NCT00030667 | Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00969917 | Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma | withdrawn | Phase 2 | 0 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 14, 2015 | clinicaltrials |
| NCT00233948 | Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma | terminated | Phase 1 / Phase 2 | 29 | City of Hope Medical CenterOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00831844 | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 3 | Mar 30, 2015 | clinicaltrials |
| NCT00004409 | Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease | completed | Phase 2 | 36 | State University of New YorkOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT01389583 | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00093080 | Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) | completed | Phase 2 | 216 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT01267695 | Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | completed | Phase 2 | 20 | Peking UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02353429 | Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets | unknown | Phase 2 | 25 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT00282087 | Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma | completed | Phase 2 | 47 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Dec 1, 2014 | clinicaltrials |
| NCT02302651 | Non-invasive Focal Therapy for Osteoid Osteoma | unknown | Phase 2 / Phase 3 | 60 | University of Roma La SapienzaOTHER | 1 | Nov 27, 2014 | clinicaltrials |
| NCT00331643 | Ixabepilone in Treating Young Patients With Refractory Solid Tumors | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Nov 14, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT00503295 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung | completed | Phase 2 | 53 | Oncolytics BiotechINDUSTRY | 1 | Oct 2, 2014 | clinicaltrials |
| NCT00634322 | High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | terminated | Phase 2 | 7 | BTG International Inc.OTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT00060944 | A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | completed | Phase 2 | 271 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 8 | Sep 8, 2014 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 14, 2017source: clinicaltrials